CRISPR-based gene editing therapy approved by the FDA for the first time
December 8, 2023TS & G bloggerComments Off on CRISPR-based gene editing therapy approved by the FDA for the first time
In a landmark decision, the FDA greenlit two new drugs for the treatment of sickle cell disease in patients 12 and older, one of which —Vertex’s drug Casgevy — is the first approved use of genome editing technology CRISPR in the US. Bluebird Bio’s Lyfgenia also is a cell-based gene…
FDA approves first oral postpartum depression pill
Biogen and Sage Therapeutics’ collaboration to develop Zurzuvae has proved fruitful. The FDA approved the oral pill specifically for the treatment of postpartum depression (PPD), making it the first of its kind in a class of antidepressants intended specifically for new mothers. According to research by the CDC, one in…